Product information

Current status:

Marketed

Current status date:

2017-12-08

Original market date: ^{See footnote 1}

2014-03-25

Product name:

JAMP-PYRANTEL PAMOATE SUSPENSION

DIN:

02412470 Electronic product monograph is not available

Company:

JAMP PHARMA CORPORATION
1310 Rue Nobel
Boucherville
Quebec
Canada J4B 5H3

Class:

Human

Dosage form(s):

Suspension

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

OTC

American Hospital Formulary Service (AHFS): ^{See footnote 3}

08:08.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

P02CC01 PYRANTEL

Active ingredient group (AIG) number:^{See footnote5}

0108709001